Patent · US Active

Fusion proteins for improved precision in base editing

US12203077B2 · kind B2 · utility

0Cited by
0References
13Claims
0Family size

Assignee

Inventors

Key dates

Filing dateAug 28, 2018
Grant dateJan 21, 2025
Priority date
Expiry dateAug 9, 2040

Classification

  • Technology area (CPC C)Chemistry; Metallurgy
  • CPC primaryC12Y305/04005
  • WIPO fieldBiotechnology
  • WIPO sectorChemistry

Abstract

Provided are base editors containing a cytidine and a catalytically inactive version of Lachnospiraceae bacterium Cpf1 (LbCpf1). The new base editors have greatly improved editing efficiency and fidelity as compared to Cas9-based base editors, and have different editing windows.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.